Global POC Molecular Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POC Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Infectious Diseases
1.2.3 Oncology
1.2.4 Hematology and Endocrinology
1.3 Market by Application
1.3.1 Global POC Molecular Diagnostics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Research Institutes
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global POC Molecular Diagnostics Market Size (2017-2028)
2.2 POC Molecular Diagnostics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global POC Molecular Diagnostics Market Size by Region (2017-2022)
2.4 Global POC Molecular Diagnostics Market Size Forecast by Region (2023-2028)
2.5 Global Top POC Molecular Diagnostics Countries Ranking by Market Size
3 POC Molecular Diagnostics Competitive by Company
3.1 Global POC Molecular Diagnostics Revenue by Players
3.1.1 Global POC Molecular Diagnostics Revenue by Players (2017-2022)
3.1.2 Global POC Molecular Diagnostics Market Share by Players (2017-2022)
3.2 Global POC Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by POC Molecular Diagnostics Revenue
3.4 Global POC Molecular Diagnostics Market Concentration Ratio
3.4.1 Global POC Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POC Molecular Diagnostics Revenue in 2021
3.5 Global POC Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players POC Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into POC Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global POC Molecular Diagnostics Breakdown Data by Type
4.1 Global POC Molecular Diagnostics Historic Revenue by Type (2017-2022)
4.2 Global POC Molecular Diagnostics Forecasted Revenue by Type (2023-2028)
5 Global POC Molecular Diagnostics Breakdown Data by Application
5.1 Global POC Molecular Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global POC Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America POC Molecular Diagnostics Revenue by Company (2020-2022)
6.2 North America POC Molecular Diagnostics Revenue by Type (2017-2028)
6.3 North America POC Molecular Diagnostics Revenue by Application (2017-2028)
6.4 North America POC Molecular Diagnostics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe POC Molecular Diagnostics Revenue by Company (2020-2022)
7.2 Europe POC Molecular Diagnostics Revenue by Type (2017-2028)
7.3 Europe POC Molecular Diagnostics Revenue by Application (2017-2028)
7.4 Europe POC Molecular Diagnostics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific POC Molecular Diagnostics Revenue by Company (2020-2022)
8.2 Asia Pacific POC Molecular Diagnostics Revenue by Type (2017-2028)
8.3 Asia Pacific POC Molecular Diagnostics Revenue by Application (2017-2028)
8.4 Asia Pacific POC Molecular Diagnostics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America POC Molecular Diagnostics Revenue by Company (2020-2022)
9.2 Latin America POC Molecular Diagnostics Revenue by Type (2017-2028)
9.3 Latin America POC Molecular Diagnostics Revenue by Application (2017-2028)
9.4 Latin America POC Molecular Diagnostics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa POC Molecular Diagnostics Revenue by Company (2020-2022)
10.2 Middle East and Africa POC Molecular Diagnostics Revenue by Type (2017-2028)
10.3 Middle East and Africa POC Molecular Diagnostics Revenue by Application (2017-2028)
10.4 Middle East and Africa POC Molecular Diagnostics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott POC Molecular Diagnostics Products and Services
11.1.4 Abbott POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.1.5 Abbott POC Molecular Diagnostics SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 bioMerieux
11.2.1 bioMerieux Company Details
11.2.2 bioMerieux Business Overview
11.2.3 bioMerieux POC Molecular Diagnostics Products and Services
11.2.4 bioMerieux POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.2.5 bioMerieux POC Molecular Diagnostics SWOT Analysis
11.2.6 bioMerieux Recent Developments
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher POC Molecular Diagnostics Products and Services
11.3.4 Danaher POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.3.5 Danaher POC Molecular Diagnostics SWOT Analysis
11.3.6 Danaher Recent Developments
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD POC Molecular Diagnostics Products and Services
11.4.4 BD POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.4.5 BD POC Molecular Diagnostics SWOT Analysis
11.4.6 BD Recent Developments
11.5 Certest Biotec
11.5.1 Certest Biotec Company Details
11.5.2 Certest Biotec Business Overview
11.5.3 Certest Biotec POC Molecular Diagnostics Products and Services
11.5.4 Certest Biotec POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.5.5 Certest Biotec POC Molecular Diagnostics SWOT Analysis
11.5.6 Certest Biotec Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche POC Molecular Diagnostics Products and Services
11.6.4 F. Hoffmann-La Roche POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.6.5 F. Hoffmann-La Roche POC Molecular Diagnostics SWOT Analysis
11.6.6 F. Hoffmann-La Roche Recent Developments
11.7 NeoGenomics
11.7.1 NeoGenomics Company Details
11.7.2 NeoGenomics Business Overview
11.7.3 NeoGenomics POC Molecular Diagnostics Products and Services
11.7.4 NeoGenomics POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.7.5 NeoGenomics POC Molecular Diagnostics SWOT Analysis
11.7.6 NeoGenomics Recent Developments
11.8 Bionano Genomics
11.8.1 Bionano Genomics Company Details
11.8.2 Bionano Genomics Business Overview
11.8.3 Bionano Genomics POC Molecular Diagnostics Products and Services
11.8.4 Bionano Genomics POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.8.5 Bionano Genomics POC Molecular Diagnostics SWOT Analysis
11.8.6 Bionano Genomics Recent Developments
11.9 ExcitePCR
11.9.1 ExcitePCR Company Details
11.9.2 ExcitePCR Business Overview
11.9.3 ExcitePCR POC Molecular Diagnostics Products and Services
11.9.4 ExcitePCR POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.9.5 ExcitePCR POC Molecular Diagnostics SWOT Analysis
11.9.6 ExcitePCR Recent Developments
11.10 Micronics
11.10.1 Micronics Company Details
11.10.2 Micronics Business Overview
11.10.3 Micronics POC Molecular Diagnostics Products and Services
11.10.4 Micronics POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.10.5 Micronics POC Molecular Diagnostics SWOT Analysis
11.10.6 Micronics Recent Developments
11.11 Nimagen
11.11.1 Nimagen Company Details
11.11.2 Nimagen Business Overview
11.11.3 Nimagen POC Molecular Diagnostics Products and Services
11.11.4 Nimagen POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.11.5 Nimagen Recent Developments
11.12 Novigenix
11.12.1 Novigenix Company Details
11.12.2 Novigenix Business Overview
11.12.3 Novigenix POC Molecular Diagnostics Products and Services
11.12.4 Novigenix POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.12.5 Novigenix Recent Developments
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck POC Molecular Diagnostics Products and Services
11.13.4 Merck POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022)
11.13.5 Merck Recent Developments
12 POC Molecular Diagnostics Market Dynamics
12.1 POC Molecular Diagnostics Market Trends
12.2 POC Molecular Diagnostics Market Drivers
12.3 POC Molecular Diagnostics Market Challenges
12.4 POC Molecular Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global POC Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Infectious Diseases
Table 3. Key Players of Oncology
Table 4. Key Players of Hematology and Endocrinology
Table 5. Global POC Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global POC Molecular Diagnostics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global POC Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global POC Molecular Diagnostics Revenue Market Share by Region (2017-2022)
Table 9. Global POC Molecular Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global POC Molecular Diagnostics Market Share by Players (2017-2022)
Table 11. Global Top POC Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Molecular Diagnostics as of 2021)
Table 12. Ranking of Global Top POC Molecular Diagnostics Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by POC Molecular Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players POC Molecular Diagnostics Product Solution and Service
Table 16. Date of Key Manufacturers Enter into POC Molecular Diagnostics Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global POC Molecular Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global POC Molecular Diagnostics Revenue Market Share by Type (2017-2022)
Table 20. Global POC Molecular Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global POC Molecular Diagnostics Revenue Market Share by Type (2023-2028)
Table 22. Global POC Molecular Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global POC Molecular Diagnostics Revenue Market Share by Application (2017-2022)
Table 24. Global POC Molecular Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global POC Molecular Diagnostics Revenue Market Share by Application (2023-2028)
Table 26. North America POC Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America POC Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America POC Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America POC Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America POC Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America POC Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America POC Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe POC Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe POC Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe POC Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe POC Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe POC Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe POC Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe POC Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific POC Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific POC Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific POC Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific POC Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific POC Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific POC Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific POC Molecular Diagnostics Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America POC Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America POC Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America POC Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America POC Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America POC Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America POC Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America POC Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa POC Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa POC Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa POC Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa POC Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa POC Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa POC Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa POC Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott POC Molecular Diagnostics Product and Services
Table 64. Abbott POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 65. Abbott POC Molecular Diagnostics SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. bioMerieux Company Details
Table 68. bioMerieux Business Overview
Table 69. bioMerieux POC Molecular Diagnostics Product and Services
Table 70. bioMerieux POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 71. bioMerieux POC Molecular Diagnostics SWOT Analysis
Table 72. bioMerieux Recent Developments
Table 73. Danaher Company Details
Table 74. Danaher Business Overview
Table 75. Danaher POC Molecular Diagnostics Product and Services
Table 76. Danaher POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 77. Danaher POC Molecular Diagnostics SWOT Analysis
Table 78. Danaher Recent Developments
Table 79. BD Company Details
Table 80. BD Business Overview
Table 81. BD POC Molecular Diagnostics Product and Services
Table 82. BD POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 83. BD POC Molecular Diagnostics SWOT Analysis
Table 84. BD Recent Developments
Table 85. Certest Biotec Company Details
Table 86. Certest Biotec Business Overview
Table 87. Certest Biotec POC Molecular Diagnostics Product and Services
Table 88. Certest Biotec POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 89. Certest Biotec POC Molecular Diagnostics SWOT Analysis
Table 90. Certest Biotec Recent Developments
Table 91. F. Hoffmann-La Roche Company Details
Table 92. F. Hoffmann-La Roche Business Overview
Table 93. F. Hoffmann-La Roche POC Molecular Diagnostics Product and Services
Table 94. F. Hoffmann-La Roche POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 95. F. Hoffmann-La Roche POC Molecular Diagnostics SWOT Analysis
Table 96. F. Hoffmann-La Roche Recent Developments
Table 97. NeoGenomics Company Details
Table 98. NeoGenomics Business Overview
Table 99. NeoGenomics POC Molecular Diagnostics Product and Services
Table 100. NeoGenomics POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 101. NeoGenomics POC Molecular Diagnostics SWOT Analysis
Table 102. NeoGenomics Recent Developments
Table 103. Bionano Genomics Company Details
Table 104. Bionano Genomics Business Overview
Table 105. Bionano Genomics POC Molecular Diagnostics Product and Services
Table 106. Bionano Genomics POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 107. Bionano Genomics POC Molecular Diagnostics SWOT Analysis
Table 108. Bionano Genomics Recent Developments
Table 109. ExcitePCR Company Details
Table 110. ExcitePCR Business Overview
Table 111. ExcitePCR POC Molecular Diagnostics Product and Services
Table 112. ExcitePCR POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 113. ExcitePCR POC Molecular Diagnostics SWOT Analysis
Table 114. ExcitePCR Recent Developments
Table 115. Micronics Company Details
Table 116. Micronics Business Overview
Table 117. Micronics POC Molecular Diagnostics Product and Services
Table 118. Micronics POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 119. Micronics POC Molecular Diagnostics SWOT Analysis
Table 120. Micronics Recent Developments
Table 121. Nimagen Company Details
Table 122. Nimagen Business Overview
Table 123. Nimagen POC Molecular Diagnostics Product and Services
Table 124. Nimagen POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 125. Nimagen Recent Developments
Table 126. Novigenix Company Details
Table 127. Novigenix Business Overview
Table 128. Novigenix POC Molecular Diagnostics Product and Services
Table 129. Novigenix POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 130. Novigenix Recent Developments
Table 131. Merck Company Details
Table 132. Merck Business Overview
Table 133. Merck POC Molecular Diagnostics Product and Services
Table 134. Merck POC Molecular Diagnostics Revenue in POC Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 135. Merck Recent Developments
Table 136. POC Molecular Diagnostics Market Trends
Table 137. POC Molecular Diagnostics Market Drivers
Table 138. POC Molecular Diagnostics Market Challenges
Table 139. POC Molecular Diagnostics Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of FiguresFigure 1. Global POC Molecular Diagnostics Sales Market Share by Type: 2021 VS 2028
Figure 2. Infectious Diseases Features
Figure 3. Oncology Features
Figure 4. Hematology and Endocrinology Features
Figure 5. Global POC Molecular Diagnostics Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospitals and Clinics Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. POC Molecular Diagnostics Report Years Considered
Figure 11. Global POC Molecular Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global POC Molecular Diagnostics Market Size 2017-2028 (US$ Million)
Figure 13. Global POC Molecular Diagnostics Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global POC Molecular Diagnostics Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 POC Molecular Diagnostics Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global POC Molecular Diagnostics Market Share by Players in 2021
Figure 17. Global Top POC Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Molecular Diagnostics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by POC Molecular Diagnostics Revenue in 2021
Figure 19. North America POC Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 20. North America POC Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 21. North America POC Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 22. North America POC Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 23. U.S. POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 24. Canada POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 25. Europe POC Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 26. Europe POC Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 27. Europe POC Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 28. Europe POC Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 29. Germany POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 30. France POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 32. Italy POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 33. Russia POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific POC Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 35. Asia Pacific POC Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific POC Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific POC Molecular Diagnostics Revenue Share by Region (2017-2028)
Figure 38. China POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 39. Japan POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 41. India POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 42. Australia POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America POC Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 50. Latin America POC Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 51. Latin America POC Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 52. Latin America POC Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 53. Mexico POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa POC Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa POC Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa POC Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa POC Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 60. Turkey POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 62. UAE POC Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 63. Abbott Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 64. bioMerieux Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 65. Danaher Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 66. BD Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 67. Certest Biotec Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 68. F. Hoffmann-La Roche Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 69. NeoGenomics Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 70. Bionano Genomics Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 71. ExcitePCR Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 72. Micronics Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 73. Nimagen Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 74. Novigenix Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 75. Merck Revenue Growth Rate in POC Molecular Diagnostics Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed